Hengrui Eyes International Expansion Amid Slowing Home Market
This article was originally published in PharmAsia News
Executive Summary
Sustained price cuts and an ongoing compliance probe have slowed down domestic market growth, effectively pushing the Chinese domestic drug maker to venture out to the U.S., European markets and Japan.